The only way to drive innovation and improve the efficiency of the sector is to create alliances and be collaborative; to be able to do more together than separately with patient-centered objectives.
In this episode, we discuss the challenges and innovations that are transforming the landscape of drug development and clinical trials, and how we can grow in a market with so many players.
Carlos Orantes, CEO of
Alconza Clinical Research, shares his insights from over 30 years of experience in the industry, and dives into the importance of collaboration and teamwork to address all the industry challenges, emphasizing on the main objective: An approach centered on the patient.
Join us as we discuss:
- How innovation in technology is playing an important role in streamlining processes and the positive impact on patient care, experience, participation and diversity
- Insights and advice for the future of clinical trials, focusing on the impact of the patients and sites while removing barriers and finding opportunities around the world
- The role of FDA guidelines in driving innovation, particularly in diversity and decentralization
- The significance of continuous learning and mentorship in staying innovative
